Novel Approaches to Diabetes Treatment

Drucker DJ. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 2003; 26 (10): 2929–40

Defronzo RA Ratner RE Han J Effects of exenatide (extendi-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 2005; 28 (5): 1092–100

Kendall DM Riddle MC Rosenstock J Effects of exenatide (extendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 2005; 28 (5): 1083–91

Byetta monograph. Amylin Pharmaceuticals, Inc.; 2006. Available: http://pi.lilly.com/us/byetta-pi.pdf (accessed November 21, 2006)

Charbonnel B Karasik A Liu J Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. Diabetes Care 2006; 29 (12): 2638–43

Aschner P Kipnes MS Lunceford JK Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care 2006; 29 (12): 2632–7

Januvia patient information. Merck; 2006. Available: www.merck.com/product/usa/pi-circulars/j/januvia/januvia_ppi.pdf (accessed November 21, 2006)